Trial · NCT01942694
Outcomes27
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 27
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Time to Development of Diabetes | Approximately 48 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Variability of Response to Vitamin D Supplementation by Baseline Characteristic: 25OHD Concentration | Approximately 48 months | |||
| SECONDARY | Variability of Response to Vitamin D Supplementation by Baseline Characteristic: Race (as a Proxy for Skin Pigmentation) | Approximately 48 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Variability of Response to Vitamin D Supplementation by Baseline Characteristic: Pre-diabetes Criteria (Two vs. Three Criteria) | Approximately 48 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Variability of Response to Vitamin D Supplementation by Baseline Characteristic: BMI | Approximately 48 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Variability of Response to Vitamin D Supplementation by Baseline Characteristic: Waist Circumference | Approximately 48 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Variability of Response to Vitamin D Supplementation by Baseline Characteristic: Age | Approximately 48 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Variability of Response to Vitamin D Supplementation by Baseline Characteristic: Geographic Location (as a Proxy for Sun Exposure) | Approximately 48 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Variability of Response to Vitamin D Supplementation by Baseline Characteristic: Calcium Intake From Supplements | Approximately 48 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Blood Plasma 25OHD Concentration. | Approximately 48 months | |||
| SECONDARY | Number of Participants With Adverse Events. | Approximately 48 months | |||
| SECONDARY | Change in Blood Pressure as a Continuous Variable. | Approximately 48 months | |||
| SECONDARY | Number of Participants Who Discontinue Study Pills. | Approximately 48 months | |||
| SECONDARY | Change in FPG as a Continuous Variable. | Every 12 months for approximately 48 months | |||
| SECONDARY | Change in 2hPG as a Continuous Variable. | Every 12 months for approximately 48 months. | |||
| SECONDARY | Change in HbA1c as a Continuous Variable. | Every 6 months for approximately 48 months | |||
| SECONDARY | Measurement of Insulin Resistance (Derived From the OGTT). | Every 12 months for approximately 48 months | |||
| SECONDARY | Measurement of Beta Cell Secretion (Derived From the OGTT) | Every 12 months for approximately 48 months | |||
| SECONDARY | Identification of Characteristics Associated With the Variability in Achieved 25OHD Concentration. | Every 12 months for approximately 48 months | |||
| OTHER_PRE_SPECIFIED | Variability of Response to Vitamin D Supplementation by Baseline Characteristic: Sex | Approximately 48 months. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01942694/outcomes